Oregovomab
- Generic Name
- Oregovomab
- Drug Type
- Biotech
- CAS Number
- 213327-37-8
- Unique Ingredient Identifier
- HX101E7L6S
Overview
Oregovomab is a murine monoclonal antibody that attaches to the tumor-associated antigen CA125.
Background
Oregovomab is a murine monoclonal antibody that attaches to the tumor-associated antigen CA125.
Indication
Investigated for use/treatment in ovarian cancer.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath